Uveoscleral Outflow Enhancement as a Complementary Bio-intervention after Failed Prior Trabecular Outflow Treatment: 12-Month Outcomes of Allograft-reinforced Cyclodialysis in Open Angle Glaucoma

Background: Eyes with open-angle glaucoma uncontrolled after a trabecular outflow procedure have limited options before progressing to bleb-forming surgery. The uveoscleral pathway is distinct, relatively pressure-independent, and conjunctiva-sparing. We report 12-month outcomes of standalone allograft-reinforced cyclodialysis in eyes with IOP that remained uncontrolled after prior trabecular outflow intervention. Methods: Analysis of a multicentre registry (CREST; NCT05506423 ). Eligible eyes had at least one prior trabecular outflow procedure, no prior bleb-forming surgery, and underwent uveoscleral outflow bio-intervention with at least 12 months of follow-up. IOP reported as mean with 95% CI, medication as mean ± SD. Results: Forty-seven eyes were eligible; 91.5% completed 12 months. Consistent with moderate-to-advanced glaucoma, baseline IOP was 22.5 mmHg (20.1, 24.9) on 3.0 (1.3) IOP-lowering medications, with visual field mean deviation −11.7 dB (8.1). 95.7% were pseudophakic. In the per-protocol efficacy analysis, IOP fell 6.1 mmHg (3.7, 8.6), a 25.0% reduction (15.5%, 34.5%; p < 0.001), with no increase in medication. At 12 months, the Kaplan-Meier estimate of freedom from incisional reoperation was 78.2% (61.8%, 88.2%). There were no vision-threatening, clinically significant adverse events associated with the procedure such as persistent hypotony, maculopathy or other complications. Conclusions: In eyes with inadequately controlled IOP following prior trabecular intervention, standalone allograft-reinforced cyclodialysis was associated with clinically meaningful IOP reduction without an increase in medication burden or permanent vision loss.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.26367933
Primary Topic
Glaucoma and retinal disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Uveoscleral Outflow Enhancement as a Complementary Bio-intervention after Failed Prior Trabecular Outflow Treatment: 12-Month Outcomes of Allograft-reinforced Cyclodialysis in Open Angle Glaucoma

Hari Jayaram, Gus Gazzard, Tsontcho Ianchulev, James C. Tsai et al.
7 links
medRxiv
Glaucoma and retinal disorders
preprint

Uveoscleral Outflow Enhancement as a Complementary Bio-intervention after Failed Prior Trabecular Outflow Treatment: 12-Month Outcomes of Allograft-reinforced Cyclodialysis in Open Angle Glaucoma

Hari Jayaram, Gus Gazzard, Tsontcho Ianchulev, James C. Tsai, Inder Paul Singh, Reena A Garg, Robert Stameper
preprint en

Abstract

Background: Eyes with open-angle glaucoma uncontrolled after a trabecular outflow procedure have limited options before progressing to bleb-forming surgery. The uveoscleral pathway is distinct, relatively pressure-independent, and conjunctiva-sparing. We report 12-month outcomes of standalone allograft-reinforced cyclodialysis in eyes with IOP that remained uncontrolled after prior trabecular outflow intervention. Methods: Analysis of a multicentre registry (CREST; NCT05506423 ). Eligible eyes had at least one prior trabecular outflow procedure, no prior bleb-forming surgery, and underwent uveoscleral outflow bio-intervention with at least 12 months of follow-up. IOP reported as mean with 95% CI, medication as mean ± SD. Results: Forty-seven eyes were eligible; 91.5% completed 12 months. Consistent with moderate-to-advanced glaucoma, baseline IOP was 22.5 mmHg (20.1, 24.9) on 3.0 (1.3) IOP-lowering medications, with visual field mean deviation −11.7 dB (8.1). 95.7% were pseudophakic. In the per-protocol efficacy analysis, IOP fell 6.1 mmHg (3.7, 8.6), a 25.0% reduction (15.5%, 34.5%; p < 0.001), with no increase in medication. At 12 months, the Kaplan-Meier estimate of freedom from incisional reoperation was 78.2% (61.8%, 88.2%). There were no vision-threatening, clinically significant adverse events associated with the procedure such as persistent hypotony, maculopathy or other complications. Conclusions: In eyes with inadequately controlled IOP following prior trabecular intervention, standalone allograft-reinforced cyclodialysis was associated with clinically meaningful IOP reduction without an increase in medication burden or permanent vision loss.

medRxiv
University of California, San Francisco (US), New York Eye and Ear Infirmary (US), Georgetown University Medical Center (US), Moorfields Eye Hospital (GB)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon